Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Intravenous iodinated contrast agents: risks and problematic situations.

Kimmie L Bui1, Joseph D Horner, Brian R Herts

  • 1Department of Diagnostic Radiology, Cleveland Clinic, OH 44195, USA.

Cleveland Clinic Journal of Medicine
|May 18, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reply.

Journal of the American College of Radiology : JACR·2025
Same author

Potential Frameworks for Communicating Diagnostic Certainty in Radiology Reports: From the ACR Commission on Quality and Safety.

Journal of the American College of Radiology : JACR·2025
Same author

Overview of three decades of management patterns of renal angiomyolipomas.

The French journal of urology·2025
Same author

Using CT-Based Pelvimetry and Visceral Obesity Measurements to Predict Total Mesorectal Excision Quality for Patients Undergoing Rectal Cancer Surgery.

Diseases of the colon and rectum·2024
Same author

Visceral adipose tissue volume effect in Crohn's disease using reduced exposure CT enterography.

Journal of applied clinical medical physics·2023
Same author

Factors predicting the active treatment of renal angiomyolipoma: 30 years of experience in two tertiary referral centers.

Frontiers in surgery·2023

Intravenous contrast media enhance diagnostic imaging but carry risks, including contrast-induced nephropathy. Careful patient selection and monitoring are crucial when using these agents.

Area of Science:

  • Radiology
  • Nephrology
  • Pharmacology

Background:

  • Diagnostic imaging frequently utilizes intravenous contrast media for disease evaluation.
  • While generally safe, these agents present potential risks.
  • Contrast-induced nephropathy is a significant concern associated with their use.

Purpose of the Study:

  • To review the risks associated with intravenous contrast media.
  • To highlight contrast-induced nephropathy as a primary risk.
  • To discuss the implications for patient care in diagnostic imaging.

Main Methods:

  • Literature review of studies on contrast media safety.
  • Analysis of reported adverse events, focusing on nephropathy.
  • Synthesis of current understanding of risk factors and prevention strategies.

Related Experiment Videos

Main Results:

  • Intravenous contrast media are essential but not without risk.
  • Contrast-induced nephropathy remains a key adverse event.
  • Risk assessment and management are critical for safe utilization.

Conclusions:

  • The benefits of contrast-enhanced imaging must be weighed against potential risks.
  • Minimizing contrast-induced nephropathy requires vigilant clinical practice.
  • Further research into safer contrast agents and protocols is warranted.